Purdue Approaches States in Bid to Settle Opioid Claims
- Lawyers said to start talks with states who haven’t yet sued
- Purdue said to hire ‘Queen of Torts’ to create settlement plan
This article is for subscribers only.
Oxycontin maker Purdue Pharma LP is proposing a global settlement in an attempt to end state investigations and lawsuits over the U.S. opioid epidemic, according to people familiar with the talks.
Purdue’s lawyers raised the prospect with several southern-state attorneys general who haven’t sued the company, as they try to gauge interest for a more wide-ranging deal, said four people who asked not to be identified because the talks aren’t public.